{"id":"https://openalex.org/W3033170367","doi":"https://doi.org/10.1093/ndt/gfaa144.p0336","title":"P0336INHIBITION C-C CHEMOKINE RECEPTOR TYPE 2 (CCR2) ON ACTIVATED KIDNEY PARIETAL EPITHELIAL CELLS REVEALS A NEW THERAPEUTIC APPROACH FOR CHRONIC KIDNEY DISEASES","display_name":"P0336INHIBITION C-C CHEMOKINE RECEPTOR TYPE 2 (CCR2) ON ACTIVATED KIDNEY PARIETAL EPITHELIAL CELLS REVEALS A NEW THERAPEUTIC APPROACH FOR CHRONIC KIDNEY DISEASES","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3033170367","doi":"https://doi.org/10.1093/ndt/gfaa144.p0336","mag":"3033170367"},"language":"en","primary_location":{"id":"doi:10.1093/ndt/gfaa144.p0336","doi":"https://doi.org/10.1093/ndt/gfaa144.p0336","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ndt/gfaa144.p0336","pdf_url":"https://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa144.P0336/33360901/gfaa144.p0336.pdf","source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa144.P0336/33360901/gfaa144.p0336.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101852012","display_name":"Bin N. Zhao","orcid":"https://orcid.org/0000-0001-7828-1605","observed_orcids":["https://orcid.org/0000-0001-7828-1605"]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Zhao","raw_affiliation_strings":["ChemoCentryx Inc., Biology, Mountain View, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc., Biology, Mountain View, United States of America","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112312397","display_name":"Zhenhua Miao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhenhua Miao","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102805861","display_name":"James J. Campbell","orcid":"https://orcid.org/0000-0003-4252-5182","observed_orcids":["https://orcid.org/0000-0003-4252-5182","https://orcid.org/0000-0000-0003-4252"]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Campbell","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015756622","display_name":"Linda S. Ertl","orcid":"https://orcid.org/0000-0003-0060-5395","observed_orcids":["https://orcid.org/0000-0003-0060-5395"]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda S Ertl","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100445116","display_name":"Yu Wang","orcid":"https://orcid.org/0000-0001-8826-7911","observed_orcids":["https://orcid.org/0000-0001-8826-7911"]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Wang","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chris Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Li","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101782525","display_name":"Rajinder Singh","orcid":"https://orcid.org/0000-0001-5981-535X","observed_orcids":["https://orcid.org/0000-0001-5981-535X"]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajinder Singh","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112383993","display_name":"Israel F. Charo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Israel F Charo","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078844354","display_name":"Thomas J. Schall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131827","display_name":"ChemoCentryx (United States)","ror":"https://ror.org/04gp12571","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131827"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J Schall","raw_affiliation_strings":["ChemoCentryx Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemoCentryx Inc","institution_ids":["https://openalex.org/I4210131827"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210131827"],"apc_list":{"value":3474,"currency":"EUR","value_usd":3926},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07993154,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"Supplement_3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.04569999873638153,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr2","display_name":"CCR2","score":0.859000027179718},{"id":"https://openalex.org/keywords/chemokine-receptor-inhibition","display_name":"chemokine receptor inhibition","score":0.7910000085830688},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.7160000205039978},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/focal-segmental-glomerulosclerosis","display_name":"focal segmental glomerulosclerosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8769999742507935},{"id":"https://openalex.org/keywords/adriamycin-nephropathy","display_name":"adriamycin nephropathy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/5-6-nephrectomy","display_name":"5/6 nephrectomy","score":0.9020000100135803},{"id":"https://openalex.org/keywords/db-db-mice","display_name":"db/db mice","score":0.8980000019073486},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5059999823570251},{"id":"https://openalex.org/keywords/glomerular-cells","display_name":"glomerular cells","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C206615009","wikidata":"https://www.wikidata.org/wiki/Q4035572","display_name":"CCR2","level":5,"score":0.8621864318847656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5989491939544678},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5822140574455261},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.5683519244194031},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.45314037799835205},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.4528749883174896},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.45239654183387756},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41515469551086426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40122032165527344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24160507321357727},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1759054958820343},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1569128930568695}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ndt/gfaa144.p0336","doi":"https://doi.org/10.1093/ndt/gfaa144.p0336","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ndt/gfaa144.p0336","pdf_url":"https://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa144.P0336/33360901/gfaa144.p0336.pdf","source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ndt/gfaa144.p0336","doi":"https://doi.org/10.1093/ndt/gfaa144.p0336","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ndt/gfaa144.p0336","pdf_url":"https://academic.oup.com/ndt/article-pdf/35/Supplement_3/gfaa144.P0336/33360901/gfaa144.p0336.pdf","source":{"id":"https://openalex.org/S186113128","display_name":"Nephrology Dialysis Transplantation","issn_l":"0931-0509","issn":["0931-0509","1460-2385"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephrology Dialysis Transplantation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3033170367.pdf","grobid_xml":"https://content.openalex.org/works/W3033170367.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2950612176","https://openalex.org/W2559144666","https://openalex.org/W2104848192","https://openalex.org/W4396997050","https://openalex.org/W2024272971","https://openalex.org/W3033738057","https://openalex.org/W2950295049","https://openalex.org/W2024641784","https://openalex.org/W2978888709","https://openalex.org/W6902130469"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,17,28,58,93,102,124,235,237,266,270,315,321,397,415,438,448],"Aims":[3],"We":[4,334],"have":[5,148],"recently":[6],"demonstrated":[7],"that":[8,170,367,405,426,459,504],"small":[9],"molecule":[10],"inhibitors":[11,121],"of":[12,24,37,85,100,109,119,141,152,173,201,216,242,257,294,310,323,330,341,370,378,441,466,481,484,515],"CCR2":[13,38,69,77,110,120,142,160,185,192,202,219,229,278,286,325,406,428,460,501,505],"rapidly":[14],"reduced":[15,435],"proteinuria":[16,437],"preserved":[18],"renal":[19,73,145,176,289,357,468],"structure":[20],"in":[21,43,46,61,122,144,153,187,197,318,327,338,354,368,393,411,418,444,478,487,493,498],"animal":[22],"models":[23,156,293,483],"diabetic":[25,49,301,450],"nephropathy":[26,50,155,302,363,447,451],"(DN)":[27],"focal":[29],"segmental":[30],"glomerular":[31,249,379,495],"sclerosis":[32],"(FSGS).":[33],"Similar":[34],"beneficial":[35],"effects":[36,60],"inhibition":[39,70,143,502],"were":[40,251,304],"also":[41],"observed":[42,335],"DN":[44,123],"patients":[45],"a":[47,150,171,224,254,324,464,479,509],"large":[48],"Phase":[51],"2":[52],"clinical":[53],"trial.":[54],"Despite":[55],"its":[56],"rapid":[57,116],"robust":[59],"these":[62,127],"kidney":[63,133,164,189,331,416,421,476,517],"diseases,":[64,146],"the":[65,86,98,115,138,188,214,217,240,299,308,319,328,339,361,430,439,445,456,488,494,513],"mechanism":[66],"by":[67,96,205,231,253,260,351],"which":[68,198],"affords":[71],"such":[72],"protection":[74],"remains":[75],"unclear.":[76],"is":[78,161,212,455,461,472],"well-known":[79],"to":[80,157,284,306,395,500],"be":[81],"expressed":[82,162,381],"on":[83,163,288,463],"cells":[84,179,250,314,345,350,373,380,392],"immune":[87,106],"system,":[88],"where":[89],"it":[90],"mediates":[91],"inflammation":[92],"immunological":[94],"functions":[95],"controlling":[97],"trafficking":[99],"monocytes":[101],"T":[103],"cells.":[104,166,290],"However,":[105],"cell":[107,413],"expression":[108,186,211,287],"may":[111,507],"not":[112,130],"adequately":[113],"explain":[114],"pharmacologic":[117],"benefits":[118],"FSGS":[125],"because":[126],"diseases":[128],"do":[129],"exhibit":[131],"appreciable":[132],"inflammation.":[134],"To":[135,183],"better":[136],"understand":[137],"protective":[139],"mechanism(s)":[140],"we":[147,190,365,424],"used":[149,191,283,305],"variety":[151,480],"vivo":[154],"determine":[158,285],"if":[159],"parenchymal":[165],"Our":[167],"results":[168],"suggest":[169],"subset":[172,465],"CD45":[174],"negative,":[175],"parietal":[177,312,343],"epithelial":[178,313,344],"express":[180],"CCR2.":[181],"Method":[182],"characterize":[184],"RFP":[193,279],"heterozygous":[194,280],"mice":[195,281],"(CCR2RFP/+)":[196],"one":[199],"copy":[200],"was":[203,282,399],"replaced":[204],"red":[206],"fluorescent":[207],"protein":[208],"(RFP),":[209],"whose":[210],"under":[213],"control":[215],"endogenous":[218],"promoter.":[220],"This":[221,454,470],"approach":[222,511],"provided":[223],"highly":[225,400],"sensitive":[226],"method":[227],"for":[228,239,512],"detection":[230],"both":[232,317,436],"flow":[233,352],"cytometry":[234],"immunofluorescence,":[236],"compensated":[238],"lack":[241],"validated,":[243],"commercially":[244],"available":[245],"anti-CCR2":[246],"antibodies.":[247],"Enriched":[248],"obtained":[252],"non-enzymatic":[255],"disruption":[256],"kidneys,":[258],"followed":[259],"centrifugation":[261],"at":[262],"low":[263],"speed":[264],"(80gs),":[265],"sieving":[267],"through":[268],"300\u00b5m":[269],"150\u00b5m":[271],"meshes.":[272],"The":[273],"Adriamycin":[274],"(ADR)-nephropathy":[275],"model":[276,303],"with":[277,402,429],"5/6":[291,446],"nephrectomy":[292],"FSGS,":[295],"as":[296,298,348],"well":[297],"db/db":[300,449],"access":[307],"change":[309],"activated":[311,342,371,442,467,491],"proteinuria,":[316,403],"presence":[320],"absence":[322],"inhibitor":[326],"setting":[329],"injury.":[332,422],"Results":[333],"dramatic":[336],"increases":[337],"number":[340,440],"(PECs,":[346],"identified":[347],"CD133+CD24+CD44hi":[349],"cytometry)":[353],"all":[355],"three":[356],"disease":[358],"models.":[359,452],"In":[360],"ADR":[362,419],"model,":[364],"found":[366,425],"30-40%":[369],"PEC":[372,412],"within":[374],"an":[375,408],"enriched":[376,496],"population":[377,471],"CCR2/RFP.":[382],"CD44hi":[383,390],"RFP+":[384],"increased":[385],"much":[386],"more":[387],"dramatically":[388],"than":[389],"RFP-":[391],"response":[394,499],"ADR,":[396],"this":[398],"correlated":[401],"suggesting":[404],"plays":[407],"important":[409],"role":[410],"activation":[414],"pathology":[417],"induced":[420],"Furthermore,":[423],"blocking":[427],"CCR2-specific":[431],"antagonist":[432],"CCX872":[433],"significantly":[434],"PECs":[443,492],"Conclusion":[453],"first":[457],"report":[458],"present":[462],"PECs.":[469],"markedly":[473],"upregulated":[474],"during":[475],"injury":[477],"murine":[482],"nephropathy.":[485],"Changes":[486],"abundance":[489],"CCR2+":[490],"preparations":[497],"suggests":[503],"antagonism":[506],"represent":[508],"novel":[510],"treatment":[514],"chronic":[516],"disease.":[518]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-06-12T00:00:00"}